NCT02956603

Brief Summary

The primary purpose of this study is to determine the extent to which the Regenerative Peripheral Nerve Interface ( i.e. reinnervation of partial muscle grafts by residual peripheral nerves) enables both the generation of high-performance motor control signals for prosthetic limbs, and the input of sensory percepts by electrical stimulation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 2, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 7, 2016

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2020

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

5.2 years

First QC Date

November 2, 2016

Last Update Submit

July 20, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Amplitude of EMG signal

    <4 hours

  • Number of separate sensory percepts evoked

    <4 hours

Study Arms (3)

Neuroma Graft

EXPERIMENTAL

In this arm, participants have already had partial muscle grafts placed on the amputated nerves to control neuroma growth. The investigators will place small electrodes percutaneously into the muscle grafts to record EMG signals and electrically stimulate the implanted nerves.

Other: Fine wire EMG electrodes

Prosthetic Control Graft

EXPERIMENTAL

In this arm, participants will have an initial surgery to place partial muscle grafts on the amputated nerves. After a healing period, the investigators will place small electrodes percutaneously into the muscle grafts to record EMG signals and electrically stimulate the implanted nerves.

Other: Fine wire EMG electrodes

Able Bodied

EXPERIMENTAL

The investigators will place small electrodes percutaneously into intact muscles in the arm to record EMG signals and electrically stimulate the intact nerves nearby.

Other: Fine wire EMG electrodes

Interventions

Electrodes placed either in partial muscle grafts or in intact muscle to record and stimulate

Able BodiedNeuroma GraftProsthetic Control Graft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For the prosthetic control graft arm:
  • Must have previously undergone upper limb amputation
  • Must be otherwise healthy (e.g. no severe pain syndromes or untreated mental health disorders)
  • Must be American Society of Anesthesiologists (ASA) Class I (low surgical risk)
  • Must have sufficient soft tissue quality to support performance of the operative procedures
  • Must have NOT previously received the partial muscle graft surgery
  • For the neuroma graft arm:
  • Must have previously undergone upper limb amputation
  • Must be otherwise healthy (e.g. no severe pain syndromes or untreated mental health disorders)
  • Must have previously received the partial muscle graft surgery
  • For the able-bodied arm:
  • Must have NOT undergone upper limb amputation
  • Must be in good health

You may not qualify if:

  • For the prosthetic control graft arm:
  • For the able-bodied arm:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Amputation, Traumatic

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Robert Oneal Professor and Chief of Plastic Surgery; Professor, Biomedical Engineering

Study Record Dates

First Submitted

November 2, 2016

First Posted

November 7, 2016

Study Start

September 6, 2015

Primary Completion

November 12, 2020

Study Completion

November 12, 2020

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared